Speaker illustration

Professor Sian E Harding

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Sian Harding is Professor of Cardiac Pharmacology at Imperial College London and Director of the British Heart Foundation Cardiovascular Regenerative Medicine Centre there. Her work has centred on the myocardium in heart failure, especially beta-adrenergic mechanisms. She was Scientific PI on the first UK Gene therapy Trial in LVAD patients, aimed at improving cardiac contractility. She is now studying the pluripotent stem cell-derived cardiomyocyte, both for disease modelling and cardiac repair. Professor Harding is former President of the European Section of the International Society for Heart Research and Board member of the British Society of Gene and Cell Therapy. She is on the Stem Cell Advisory panel for the Cell and Gene Therapy Catapult.

The role of microdomains in beta-adrenoreceptor signalling

Event: Frontiers in CardioVascular Biology 2016

Topic: Molecular biology / genetics

Session type: Featured Symposium


Moderated Poster session - Heart

Event: Frontiers in CardioVascular Biology 2016

Topic: Miscellaneous

Session type: Moderated Posters


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb